January 2018

NCI Standard Funding Opportunity Announcements

Current and Recent Program Announcements  |  Current and Recent Requests for Applications
Current and Recent NCI and Trans-NIH Initiatives | Requests for Proposals  |  Standard Due Dates

Ongoing All Ranks Federal See BAA

Army Research Office Broad Agency Announcement (BAA)
Basic and Applied Scientific Research W911NF-17-S-0002-01
April 2017 - March 2022

The purpose of this BAA is to solicit research proposals in the engineering, physical, life, and information sciences for submission to the Army Research Office (ARO) for consideration for possible funding. Whitepapers and proposals will be evaluated only if they are for fundamental scientific study and experimentation directed toward advancing the scientific state of the art or increasing basic knowledge and understanding.  
Due Dates: Open until Mar. 31, 2022
Proposers are to submit white papers prior to submission of a complete proposal. Based on assessment of white papers, feedback will be provided to encourage or discourage submission of full proposals.
Amount & Project Period: No specific dollars have been reserved - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research - (x6804)
Links: ARO CORE BAA-W911NF-12-R-0012-Mod 03


Open All Ranks Non-federal Clinical Trials

The Gateway for Cancer Research
Research Grants

Gateway focuses on transformational science via effective clinical trials - when basic science translates into human testing and clinical practice.
Due Dates: Rolling requests for funding conducted in two stages: a Letter of Intent (LOI) and if invited, a full application. Applicants must submit via Gateway's Grant Management System
Amount & Project Period: Funding is variable and duration is 1 to 3 years
Eligibility: All Ranks
Contact: Gateway Contacts are: Jerian Dixon-Evans, Research Grants Specialist  Jerian.Dixon-Evans@gatewaycr.org (847) 342-7361 and Domarina Oshana, Ph.D., Director of Research and Grants Domarina.Oshana@gatewaycr.org (847) 342-7443
Link: Grant Application Process


December 20 (Pre-application) See Below Federal Kidney

Congressionally Directed Medical Research Programs (CDMRP)
Kidney Cancer Research Program (KCRP)

Due Dates: Dec. 20 (Pre-application)
Applications Due:  Jan. 02 (OSR) Ι Jan. 4 (Sponsor)
Contact: Office of Sponsored Research - (x6804)
Primary Link: FY17 Kidney Cancer Research Program (KCRP)

Consortium Development Award - W81XWH-17-KCRP-CDA

The goal of the Consortium Development Award is the establishment of the consortium infrastructure for future multi-institutional clinical trials.  The consortium must be a geographically dispersed coalition, including a Coordinating Center and at least three Clinical Trial Sites.
Amount & Project Period: $1,000,000 (Total) - 2 years
Eligibility: An eligible PI (who will be Consortium Director) will be a faculty member at or above Asst. Professor level (or equiv.), and should have a strong background and expertise in kidney cancer. PIs of proposed Clinical Trial Sites should have a strong background and expertise in kidney cancer.
PA Link: W81XWH-17-KCRP-CDA Ι Application Instructions
 

Idea Development Award - W81XWH-17-KCRP-IDA

This award is intended to support innovative ideas and high-impact approaches based on scientifically sound evidence to move toward the KCRP vision of eliminating kidney cancer. Research should include a well-formulated, testable hypothesis based on strong scientific rationale and a well-developed and articulated research approach.  Clinical trials are not allowed.
Amount & Project Period: $400,000 (Direct Costs) - 3 years
Eligibility: Established investigators (EIs) - At or above the level of Assistant Professor (or equivalent) and 10 years or more from a terminal degree.
Early-Career Investigators (ECIs) - W/in 10 years of completing terminal degree (doctorate or any medical degree), excluding time spent in medical residency, or during family medical leave. Applicant should clearly delineate how s/he meets these eligibility criteria in the biographical sketch. Time spent as a postdoctoral fellow is not excluded and must be within the 10-year span from the time of terminal degree. Mentorship is required, and a Career Development Plan is required to be submitted by ECIs only.
PA Link: W81XWH-17-KCRP-IDA Ι Application Instructions

Concept Award - W81XWH-17-KCRP-CA

This award allows Principal Investigators (PIs) the opportunity to pursue serendipitous observations. Preliminary data are not allowed.  Applications must describe how the new idea will enhance the existing knowledge of kidney cancer or develop an innovative and novel course of investigation.  Clinical trials are not allowed.
Amount & Project Period: $75,000 - 1 year
Eligibility: All Ranks
PA Link: W81XWH-17-KCRP-CA Ι Application Instructions
 

Translational Research Partnership Award - W81XWH-17-KCRP-TRPA

This award supports development of translational research collaborations between two independent, faculty level (or equiv.) investigators to address a central problem or question in kidney cancer in a manner that would be less readily achievable through separate efforts.  One partner in the collaboration must be a research scientist and the other must be a clinician.  This award is structured to accommodate two PIs, referred to as the Initiating PI and the Partnering PI, each of whom will receive a separate award.
Amount & Project Period: $600,000 (Direct Costs) - 3 years
Eligibility: Initiating PI must be at or above Asst. Professor or equiv. level; Partnering PI must be at or above Asst. Professor or equiv. level; Postdoctoral fellows are not eligible to be Partnering PIs.
One partner in the collaboration must be a research scientist and the other must be a clinician.
PA Link: W81XWH-17-KCRP-TRPA Ι Application Instructions
December 21 See Below Non-federal Lung

American Lung Association
Current Funding Opportunities

Due Dates: Dec. 19 (OSR) Ι Dec. 21 (1:00, pm EST) (Sponsor)
General Eligibility: Candidate must be U.S. citizen or foreign national holding one of the following: permanent resident (Green Card), exchange visitor (J-1), temporary worker in a specialty occupation (H-1B), Canadian or Mexican citizen engaging in professional activities (TN), Australians in Specialty Occupation (E-3) or temporary worker with extraordinary abilities in the sciences (O-1). At time of application and throughout award, applicant must be employed by a U.S. institution.
Contact: Office of Sponsored Research - (x6804)
Primary Link: Awards and Grants Opportunities
 

Senior Research Training Fellowship (RT)

The objective is to support first time training of recently graduated MDs and PhDs seeking further academic training as scientific investigators researching the mechanisms of lung disease and general lung biology.
Amount & Project Period: $65,000 - 2 years
Eligibility: Applicant must hold a doctoral degree. PhD applicants must be in 1st or 2nd year of postdoctoral training at the time of application.
MD or DO applicants must also have completed clinical training, have some research experience, and be in 3rd or 4th year of fellowship training at time of application. Fellows with small amounts of clinical training to complete or clinical activity are eligible, but must have a minimum of 75% effort devoted to research.
Link: Award Terms and Conditions and Application Guide

Biomedical Research Grant

This is a mentored award meant to provide seed monies to junior investigators on the path to independence for researching the mechanisms of lung disease and general lung biology.
Amount & Project Period: $100,000 - 2 years
Eligibility: Applicant must hold a doctoral degree and have a faculty appointment or equiv. w/demonstrated institutional commitment (salary support, research space.
Fellows and PhD post-docs are eligible  only if Department Chair can assure a promotion to faculty status by start of award. MD applicants must have completed two years of post-doctoral research training by start of award.
Link: Award Terms and Conditions and Application Guide
 

Clinical Patient Care Research Grant

This is a mentored award meant to provide seed monies to junior investigators on the path to independence for conducting trials for the improvement of patient care and treatment for lung disease.
Amount & Project Period: $100,000 - 2 years
Eligibility: Applicant must hold a doctoral degree and have a faculty appointment or equiv. w/demonstrated institutional commitment (salary support, research space. Fellows and PhD post-docs are eligible to apply only if Department Chair can assure a promotion to faculty status by start of award. MD applicants must have completed two years of post-doctoral research training by start of award.
Link: Award Terms and Conditions and Application Guide
R01 NCI

December 27 All Faculty Ranks Federal Program Projects

National Cancer Institute Program Project Applications (Clinical Trial Optional)

The proposed Program may address any of the broad areas of cancer research, including (but not limited to) cancer biology, cancer prevention, cancer diagnosis, cancer treatment, and cancer control. Basic, translational, clinical, and/or population-based studies in all of these research areas are appropriate. Each application submitted in response to this FOA must consist of at least three research projects and an Administrative Core. The projects must share a common central theme, focus, and/or overall objective.
Due Dates: Dec. 27 (Letter of Intent)
Jan 23 (OSR) Ι Jan. 25 (Sponsor)
Additional Due Dates:  Standard dates (w/LOI due 30 days prior)
Amount & Project Period: Application budgets are not limited - 5 years
Eligibility: All Faculty Ranks - NCI encourages P01 applicants to take advantage of the multiple PD/PI option. Use of this option allows, for example, the designation of any (or all) of the leaders of the individual projects or cores as a PD/PI of the overall application.
Contact: Office of Sponsored Research - (x6804)
RFA Link: PAR-18-290

January 01 All Ranks Non-federal Liver

Fibrolamellar Cancer Foundation (FCF)
Research Grants

The Foundation is accepting proposals to support innovative research, leading to curative treatments for fibrolamellar hepatocellular carcinoma, an aggressive teen/young adult liver cancer.  Studies should be intended to advance knowledge in the areas of FL-CC. Of particular interest are those showing a clear path to clinical trials.
Due Dates: Dec. 28 (OSR) Ι Jan. 01 (Sponsor)
Additional Due Date:  July 01
Amount & Project Period: Funding and performance period are variable.
Eligibility: All Ranks
Contact: Office of Sponsored Research - (x6804)
Links: RFP application Ι Apply for a Grant
 
January 05 All Ranks Non-federal Health Disparities

Community Foundation of Broward County
Broward Pride

Supports LGBT issues in the areas of civil rights, tolerance, the arts and health and economic disparities. Projects supported must demonstrate impact in one or more of the following areas: Increase opportunities for LGBT civil rights advocacy and education to create a more informed, tolerant and engaged community; Transform community and school environments in ways to promote and encourage acceptance and inclusion of LGBT residents; Increase production of and access to quality arts programming exploring LGBT issues; and Combat mental and physical health disparities within LGBT populations.
Due Dates: Jan. 03 (OSR) Ι Jan. 05 (Sponsor)
Amount & Project Period: $100,000 (Total Costs) - 1 year  
Eligibility: All Ranks
Contact: Office of Sponsored Research - (x6804)
Links: Overview  Ι  PhilNet Portal
R01 NCI

January 05 (LOI) All Ranks Federal Lung, Head & Neck

Biology of Lung, and Head and Neck Preneoplasias (Clinical Trial Not Allowed)

This FOA seeks applications investigating mechanistic and biological aspects of preneoplasia leading to lung, and head and neck (HN) cancers.
Due Dates: Jan. 05 (Letter of Intent)
Applications Due: Feb. 01 (OSR) Ι Feb. 05 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: Budgets not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research - (x6804)
FOA Link: PA-17-459
Companion FOA: PA-17-460, R21
R21/R33 NIH
NCI is a participating Institute

NEW
January 05 (LOI) All Ranks Federal Tobacco Use
Treatment Outcomes

Target Assessment, Engagement and Data Replicability to Improve Substance Use Disorders Treatment Outcomes (Clinical Trial Optional)

This FOA encourages applications focused on early-stage, treatment generation and pilot clinical trials consistent with an experimental therapeutic approach. This approach requires identification of a theory-derived target based on putative mechanisms of alcohol, tobacco and other drug use, and clear hypotheses about how a treatment directed at changing the target can lead to clinical benefits.
Due Dates: Jan. 05 (Letter of Intent)
Feb. 01 (OSR) Ι Feb. 05 (Sponsor)
Additional Due Dates:  Standard dates w/LOI due 30 days prior
Amount & Project Period: R21 Phase:  $275,000 (Direct Costs) - 2 years
R33 Phase:   Budget not Limited - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-18-086
Companion FOA: PAR-18-085 (R33 Clinical Trial Optional)
January 12 See Below Non-federal Desmoid Tumors

Desmoid Tumor Research Foundation

Due Dates: Jan. 10 (OSR) Jan 12 (Sponsor)
Contact: Office of Sponsored Research - (x6804)
Primary Links: The Desmoid Tumor Research Foundation  Ι  Apply for a Grant 

RFP for General Research

The Foundation funds research that will advance the current scientific knowledge about desmoid tumors, and uses cutting-edge science and creative clinical applications, in addition to novel approaches addressing potential leads based on prior research.
Amount & Project Period: $65,000/yr. - Duration is a minimum of 1 year
Eligibility: MD, PhD, or equivalent degree
Link: RFP for General Proposals

RFP for New Investigators

The purpose is to fund early stage research that will explore new approaches to advance current scientific knowledge about desmoid tumors, resulting in development of new treatment options. Specifically, this RFP seeks applications from young investigators who are new to desmoid tumor research and need seed funding to gather preliminary data to enable the applicant to apply for funding to support a more fully developed line of research in the future.
Amount & Project Period: $30,000 - 1 year
Eligibility: Must be at rank of Associate Professor or below w/MD, PhD, or equivalent degree and not have previously received funding for independent research directed at desmoid tumors.
Link: RFP for New Investigators



January 09 (1:00pm, EST) ALL Faculty Ranks Non-federal Neuroendocrine

American Association for Cancer Research Neuroendocrine Tumor Research Foundation-AACR Grant  

This grant will promote and support innovative cancer research. The purpose is to develop and study new ideas and innovative approaches having direct application and relevance to neuroendocrine tumors. Proposed research may be in any discipline of basic, translational, or clinical cancer research.
Due Dates: Jan. 05 (OSR) Ι Jan. 09 (1:00, pm EST) (Sponsor)
Amount & Project Period: $250,000  -  2 years
Eligibility: Must have a doctoral degree in a related field and be an independent investigator;
AACR membership is required;
No citizenship requirements, but non-US citizens must assure that visa status will provide sufficient time to complete project and grant term at the institution of application.
Contact: Office of Sponsored Research - (x6804)
Links: Grant Information
Program Guidelines and Application Instructions

January 12 See Below Non-federal Gastroenterology

American Gastroenterological Association

Due Dates: Jan. 10 (OSR) Ι Jan. 12 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Primary Link: AGA Program announcements

Caroline Craig Augustyn & Damian Augustyn Award

This opportunity is to support early career investigators conducting research relevant to the pathogenesis, prevention, diagnosis, or treatment of digestive cancer. The award is intended to supplement existing career development funding.
Amount & Project Period: $40,000 (Total Costs) - 1 year  
Eligibility: Must be an AGA member.
Must hold a federal or non-federal career development award related to digestive cancer.
Must hold a full-time faculty position.
Must not have an R01 award or equivalent.
Link: Guidelines

Elsevier Pilot Research Award

The objective of this pilot research award is to provide funds to early career investigators to help establish their research careers, or to support projects that represent new research directions for established investigators.
Amount & Project Period: $25,000 (Total Costs) - 1 year 
Eligibility: Must be an AGA member.
Must hold a full-time faculty position.   
Link:  Guidelines

Boston Scientific Technology and Innovation Pilot Award

The objective of this pilot research award is to provide funds for early career investigators or established investigators pursuing new research directions. Projects must focus on medical technologies relevant to the diagnosis or treatment of digestive or liver diseases.
Amount & Project Period: $30,000 (Total Costs) - 1 year  
Eligibility: Must be an AGA member.
Must have a full-time faculty position.   
Link: Guidelines
R01 NCI

January 15 (LOI) All Ranks Federal Imaging

Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01 Clinical Trial Required)

This FOA is intended to support clinical trials conducting preliminary evaluation of the safety and efficacy of imaging agents, as well as an assessment of imaging systems, image processing, image-guided therapy, contrast kinetic modeling, 3-D reconstruction and other quantitative tools. As many such preliminary evaluations are early in development, this FOA will provide investigators with support for pilot (Phase I and II) cancer imaging clinical trials, including patient monitoring and laboratory studies.
Due Dates: Jan. 15 (Letter of Intent)
Applications Due:  Feb.12 (OSR) Feb. 14 (Sponsor)
Additional 2018 Due Dates:  June 28 & Oct. 11
Amount & Project Period: Limited to $500,000 (direct costs) for total project period.  No more than $250,000 (direct costs) in any single year. - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research - (x6804)
FOA Link: PAR-17-167
Adm. Supplement NIH
NCI is a participating Institute
January 15 See Below Federal Dietary Supplements/Natural Products

Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplements and Natural Products

This FOA will build on existing NIH awards to support the performance and publication of formal single-laboratory validation studies of relevant quantitative analytical methods. The methods proposed for validation must be used to identify and quantify chemical constituents (active or marker chemical compounds, adulterants, contaminants) or metabolites thereof in experimental reagents, raw materials, and/or clinical specimens (for example urine or plasma samples). Methods must have been developed or utilized in fulfillment of the active parent grant's specific aims.
Due Dates: Jan. 11 (OSR) Ι Jan. 15 (Sponsor)
Additional Due Date:  Apr. 15
Amount & Project Period: Budgets limited to no more than 25% of Council-approved direct costs for current budget year of the project or $100,000 (direct costs), whichever is less.  Supplements may be requested for up to one year.
Studies must be accomplished w/in competitive segment of parent award which must have at least 18 months of active support remaining as of application due date.  
Eligibility: Individual(s) must hold an active grant or cooperative agreement (as specified in FOA), and research proposed for supplement must be accomplished within competitive segment of active award.
Contact: Office of Sponsored Research - (x6804)
FOA Link: PA-17-447


January 15 (Noon, EST) All Faculty Ranks Non-federal Pancreatic

Pancreatic Cancer Action Network
Translational Grant

Proposed research should aim to identify novel targets and approaches to treatment of pancreatic cancer or understand and circumvent treatment resistance. Of particular interest are research projects that fall into at least one of these three areas of research: a) Immune context and tumor microenvironment interactions, (b) Regulators of pathogenesis, progression and metabolism, with particular interest in epigenetic mechanisms and (c) Transcriptional networks essential for viability and maintenance of malignant phenotype.
Special Note: PANCAN  has partnered with Celgene Corporation to accelerate development of novel therapies by establishing strong relationships between academia and industry through research grants.  Celgene Corporation will be involved w/funded project, will have access to project results such as progress reports and will have first negotiation rights for further project development.  Further, publishable manuscripts resulting from funded projects are subject to editorial review by Celgene. If applicant believes this creates a conflict, or for further information, please contact grants@pancan.org  before applying.
Due Dates: Jan. 11 (OSR) Ι Jan. 15 (Sponsor, Noon, EST)
Amount & Project Period: $500,000 - 2 years (Contingent on success, projects may be expanded to a 3rd year (w/an additional $250,000). Expansion will be determined separately from this application
Eligibility: All Faculty Ranks
Contact: Office of Sponsored Research - (x6804)
Links: Apply Now for a Pancreatic Cancer Research Grant
Guidelines
proposalCENTRAL
January 16 See Below Non-federal Radiology

Radiological Society of North America (RSNA)
RSNA Research & Education Foundation  
Research Grants

Due Dates: Jan. 12 (OSR) Ι Jan. 16 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Primary Link: Grants and Awards
NEW

Research Scholar Grant

The project can be in any area of research related to radiologic sciences, from hypothesis-driven basic science and clinical investigations to topics such as drug, device, and therapy development; comparative effectiveness, evidence-based radiology, ethics and professionalism, quality improvement, clinical practice efficiency, and imaging informatics.
Amount & Project Period: $150,000 - 2 years
Eligibility: Must be an RSNA Member at the time of application;
Only one new nomination may be submitted per department per year;
Must hold a full-time faculty position in a department of radiology, radiation oncology, or nuclear medicine, and be w/in 5 years of initial faculty appointment w/academic rank of instructor, asst. professor, (or equiv.) at time of application; Must have completed advanced training and be certified by American Board of Radiology (ABR)/The Royal College of Physicians and Surgeons of Canada, or on track for certification.
Minimum 40% effort 
See announcement for additional detail
Links Details/Application Ι Policies and Procedures
 

Research Resident/Fellow

Grant Projects may be for any area of research related to the radiologic sciences.  Projects focused on advancing imaging science, developing or evaluating medical imaging technology, or making innovative use of imaging science to answer important biologic or clinical questions are encouraged. This program is not intended to support those whose primary aim is to obtain practical experience in clinical radiology or to fund PhD post-doc projects.
Amount & Project Period: Research Resident project:  $30,000 - 1 year
Research Fellow:  $50,000 - 1 year
Eligibility: Must be RSNA Member at the time of application;
Must be resident or fellow in department of radiology, radiation oncology, nuclear medicine or medical physics at time of application
See Eligibility for additional detail.
Links: Details/Application Ι Policies and Procedures

Research Seed Grant

Projects focused on advancing imaging science, developing or evaluating medical imaging technology, or making innovative use of imaging science to answer important biologic or clinical questions are encouraged.
Amount & Project Period: $40,000 - 1 year
Eligibility: All Faculty Ranks
Must be RSNA Member at the time of application
Must not have been PI on external/extramural grant/contract amounts totaling more than $60,000 USD in a single year;
See Eligibility for additional details
Links: Details/Application Ι Policies and Procedures


January 16 (LOI) All Faculty Ranks Non-federal ALK-Positive Lung Cancer

LUNGevity Foundation
2018 ALK-Positive Lung Cancer Transformational Research Award

The project to be funded is expected to have a direct impact on the outcomes of patients with ALK-positive lung cancer, but innovative proposals that address other unmet needs in the ALK-positive lung cancer space are also invited for submission. Applicants are encouraged to propose projects that utilize the resources of the ALK Positive members, which include their available histories, opinions, tissues, bodily fluids, and any other aspects of their condition.
Due Dates: Jan.16 (Letter of Intent)
Invited Applications: Mar. 21 (OSR) Ι Mar. 23 (Sponsor)
Amount & Project Period: $200,000  - 2 years, subject to 6 moth reviews
Eligibility: Must hold doctoral degree and faculty appointment
Contact: Office of Sponsored Research - (x6804)
Links: Overview Ι RFA Ι proposalCENTRAL
U01 NCI

January 17 All Ranks Federal Adverse Event Data

Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability

This FOA is associated with the Beau Biden Cancer Moonshot InitiativeSM that is intended to accelerate cancer research. The purpose of this FOA is to promote research on developing the descriptive, inferential, and graphical statistical methods for data generated in clinical trials including Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAETM) items. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): Accelerate research that can identify approaches to monitor and manage patient-reported symptoms.
Due Dates: Dec. 16 (Letter of Intent)
Applications Due: Jan 15 (OSR) Ι Jan. 17(Sponsor)
Amount & Project Period: $425,000/yr. (Direct Costs) - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-CA-17-052
R25 NCI

NEW
January 25 All Ranks Federal Cancer Education/Curriculum/Methods Development

Cancer Research Education Grants Program - Curriculum or Methods Development

The over-arching goal of this NCI R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation's biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Curriculum or Methods Development. Applications are encouraged that propose innovative, state-of-the-art programs that address the cause, diagnosis, prevention, or treatment of cancer, rehabilitation from cancer, or the continuing care of cancer patients and the families of cancer patients.
Due Dates: Jan. 23 (OSR) Ι Jan. 25 (Sponsor)
Additional Due Dates:  Standard dates apply
Amount & Project Period: $150,000/yr. (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-18-476
Companion FOAs: PAR-18-477, R25 (Courses for Skills Development)
PAR-18-478, R25 (Research Experiences)


NEW
January 26 (Pre-application) All Ranks Federal Applied Science

Defense Health Program
Congressionally Directed Medical Research Programs
FY17-18 Defense Medical Research and Development Program (DMRDP)

Accelerating Innovation in Military Medicine Research Award (AIMM)

The AIMM initiative supports applied research that utilizes systematic studies to understand the means to meet a recognized and specific need...Applied research may include hypothesis-testing and/or proof-of-concept studies as well as work that refines concepts and ideas into potential solutions with a view toward evaluating technical feasibility of emerging approaches, technologies, and promising new products.
Due Dates: Jan. 26 (Pre-application)
Feb. 07 (OSR) Ι Feb. 09 (Sponsor)
Amount & Project Period: $350,000 (Direct Costs) - 18 months
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: W81XWH-17-DMRDP-AIMM 
General Submission Instructions


NEW
January 29 (LOI) Junior faculty Non-federal Career Development

American Thyroid Association (ATA)
ATA Call for Research Grants

Funds available to support new investigator initiated research projects in the area of thyroid function and disease.  Topics may include, but are not limited to, Clinical Disorders of Thyroid Function, Thyroid Autoimmunity, Thyroid Cancer, Thyroid Hormone Effect and Metabolism, and Thyroid Imaging.
Due Dates: Jan. 29 (Letter of Intent)
Invited Submissions:  April 2018
Amount & Project Period: $25,000/yr.  (Direct Costs) - 2 years
Eligibility: Must be new investigators <6 years from completion of post-doctoral fellowship and not been PI on an NIH RO1 or equiv. grant (recipients of NIH R29, R21 and KO8 awards are eligible); Postdocs are eligible if department provides written confirmation that at time of award applicant will have a junior faculty position;
Must be ATA member or apply for complimentary membership  by April 2018
Contact: Office of Sponsored Research (x6804)
Links: ATA 2018 Research Grants Ι Call for Research Grants Proposals


NEW
January 29 All Faculty Ranks Non-federal Brain Tumors

Southeastern Brain Tumor Foundation
2018 Research Grant Cycle

SBTF grant awards are viewed as seed funding for continued development of promising research programs, and support potential advances in technologies and clinically-viable treatments for brain tumors. Seed funding from SBTF will foster the continued development of emerging concepts, treatments and therapies so that researchers working in the area of brain tumors can garner national recognition and funding from larger funding agencies, such as the American Cancer Society or National Institutes of Health.
Due Dates: Jan. 25 (OSR) Ι Jan. 29 (Sponsor)
Amount & Project Period: Up to $75,000 - 1 year
Eligibility: All Faculty Ranks (Research Associates and individuals who hold equiv. non-faculty level positions are not eligible.)
Grants are limited to pre-clinical research and clinical trials
Contact: Office of Sponsored Research (x6804)
Links: 2018 Guidelines and Instructions Ι 2018 SBTF FAQs


January 31 All Ranks Non-federal Pancreatic

The National Pancreas Foundation
2018 Research Grants & Awards

Research must be in the field of pancreatic diseases. Studies intended to advance knowledge in the areas of pancreatic carcinoma, and all forms of pancreatitis would be the closest to the areas of interest.
Due Dates: Jan. 29 (OSR) Ι Jan. 31 (Sponsor)
Amount & Project Period: $50,000 - 1 year
Eligibility: All Ranks
Contact: Office of Sponsored Research - (x6804)
Link: 2018 Research Grants & Awards

NEW
January 31 All Ranks Non-federal Sarcoma

Sarcoma Foundation of America
Research Grant

This program provides grants to investigators interested in translational science sarcoma research The Foundation will only accept applications that focus on the following areas of research:
Omic characterization of sarcomas and definition of novel targets;
Omic patterns of sensitivity and resistance to existing agents;
Systemic therapy combinations;
Immunotherapy
Due Dates: Jan. 27 (OSR) | Jan. 31 (Sponsor)
Amount & Project Period: $50,000 - 1 year
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Apply for a Grant Ι proposalCENTRAL (Submission Site)


NEW
February 01 Postdocs Non-federal Career Development

Jane Coffin Childs Memorial Fund for Medical Research (JCC)
Fellowship Awards

The JCC supports research into causes and treatment of cancer, with a broad approach to the study of cell growth and development, emphasizing the study of the basic biology and chemistry of the underlying processes.
Due Dates: Jan. 30 (OSR) Ι Feb. 01 (Sponsor)
Amount & Project Period: Basic stipend:      $52,000/year 01;
                               $52,500/year 02; and
                               $53,000/year 03
                               Additional $1,000 per dependent child;
                               Allowance $2,000/year for research;
                               costs to sponsoring laboratory; but may not be
                               used for travel.
Eligibility: Postdoctoral applicants should have < 1 year of postdoctoral research experience at application deadline;
PhD. degree must not have been conferred more than 18 months prior to the deadline date;
MD. degree should not have been conferred > 3years before deadline date;
PhD. candidates without a degree at application deadline are eligible to apply. However, if awarded, PhD. degree must be conferred prior to start of Fellowship.
Contact: Office of Sponsored Research (x6804)
Links: Fellowship Information Ι Dates and Documents

NEW
February 01 All Ranks Non-federal Lung Cancer in Women

A Breath of Hope Lung Foundation
Lung Cancer in Women

This award will be focused on understanding ling cancer in women.  The goal is to fund translational projects that will evolve into clinical trials within five years.  The Foundation is also open to funding new pathways for disease diagnosis and treatment discovery.
Due Dates: Jan. 30 (OSR) Ι Feb. 01 (Sponsor)
Note that eligibility must be confirmed in order to receive a link to the online application.
Amount & Project Period: $150,000 - 2 years
Eligibility: All Ranks - Must have M.D., M.D. /Ph.D., PhD, D.O., DrPH or MS.
Contact: Office of Sponsored Research - (x6804)
Links: Tona Vives Research Award Ι Eligibility Confirmation

NEW
February 01 All Faculty Ranks Moffitt See Guidelines

Innovative Studies Funding Opportunity (Cycle 2) 

Moffitt invites its investigators to apply for grant funding to address unmet medical needs or standard of care challenges.
Due Dates: Jan. 29 (OSR) Ι Feb. 01
(OSR will submit to Alliance Management Dept.)
Amount & Project Period: $870,000 (direct costs) for up to 2 years (i.e., either $870,000 for 1 year or $435,000/yr. for 2 years)
Eligibility: All Faculty Ranks
Contact: Alliance Management Department
Link: Guidelines

NEW
February 01 All Ranks Federal PCOR/Meeting Support

Patient Centered Outcomes Research Institute (PCORI)
Engagement Award (EAIN): Research Meeting and Conference Support

This initiative can provide funding support for meetings and conferences that align with the PCORI's Mission and Strategic Plan and facilitate expansion of patient-centered outcomes research/comparative clinical effectiveness research (PCOR/CER).
Please note that the Application Guidelines have changed as of June 2, 2017.
Due Dates: Jan. 30 (OSR) Ι Feb 01 (Sponsor)
Amount & Project Period: $50,000 total costs -1 year
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: Opportunity Summary Ι EAIN Guidelines


NEW
February 01 (LOI) Junior Faculty Non-federal Career Development/Blood Cancers

Leukemia Research Foundation
Hollis Brownstein Research Grant Program for New Investigators

This program allows innovative scientists to act on their ideas, and try new procedures and experiments that will hopefully lead to significant breakthroughs. Preference given to proposals focusing on leukemia, lymphoma, MDS, and multiple myeloma.
Due Dates: Feb. 01 (Letter of Intent)
Invited Submissions:  Mar. 13 (OSR) Ι Mar. 15 (Sponsor)
Amount & Project Period: $100,000 (Total Costs) -1 year  
Eligibility: New Investigators are considered to be w/in 7 years of first independent position. Years as a resident physician, fellow physician, or post-doctoral fellow are considered to be training years;
Investigators at instructor level or similar position must include a letter from department chair confirming applicant's independence;
Applicants with an NIH KO8 or K23 are eligible.
Contact: Office of Sponsored Research (x6804)
Links: Hollis Brownstein Research Grants Program
Guidelines
Application Information


February 02 Female Postdocs Non-federal Career Development

L'Oreal USA For Women In Science and American Association for the Advancement of Science
The L'Oreal USA for Women in Science Fellowship Program

This program rewards women postdoctoral scientists for their contributions in Science, Technology, Engineering and Math (STEM) fields and commitment to serving as role models for younger generations. L’Oréal USA partners with the American Association for the Advancement of Science (AAAS) to manage the program's application and peer-review process. 
Due Dates: Jan. 31 (OSR) Ι Feb. 02 (Sponsor)
Amount & Project Period: $60,000 - 1 year
Eligibility: Must hold PhD and have started in a postdoctoral research position by February 2, 2018 and maintain status throughout fellowship year;
Must be American born, naturalized citizen or permanent resident;
See announcement for additional requirements.
Contact: Office of Sponsored Research - (x6804)
Links: About the Program Ι L'Oreal USA For Women In Science
R01 NIH


NEW
Parent R01 for investigator-initiated projects
February 05 All Ranks Federal Research Project Grants

NIH Research Project Grant (Parent R01 Clinical trial not Allowed)

The NIH Research Project Grant supports a discrete, specified, circumscribed project in areas representing the specific interests and competencies of the investigator(s). The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions.
Due Dates: Standard dates apply  This FOA must be used for applications submitted after January 25, 2018
Amount & Project Period: Application budgets are not limited - max. 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research - (x6804)
FOA Link: PA-18-484
R01 NIH
NCI is a participating Institute

NEW
February 05 All Ranks Federal Education & Health Outcomes

Education and Health: New Frontiers (Clinical Trial Optional)

The goal is to support research that will further elucidate pathways involved in the relationship between education and health outcomes and in doing so to carefully identify the specific aspects and qualities of education that are responsible for this relationship and what the mediating factors are that affect the nature of the causal relationship.
Due Dates: Feb. 01 (OSR) Ι Feb. 05 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: Application budgets not limited - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-18-387
Companion FOAs: PAR-18-362 R21 - Standard Due Dates apply
PAR-18-388 R03 - Standard Due Dates apply
R01 NCI

NEW
February 05 All Ranks Federal Immunotherapy

Metabolic Reprogramming to Improve Immunotherapy

The overall goal is to encourage applications to (a) generate a mechanistic understanding of the metabolic processes that support robust anti-tumor immune responses in vivo, (b) determine how the metabolic landscape of the tumor microenvironment affects immune effector functions, and (c) then use this information to manipulate (reprogram) the metabolic pathways used by the tumor, the immune response, or both to improve cancer immunotherapy.
Due Dates: Feb. 01 (OSR) Ι Feb. 05 (Sponsor)
Additional Due Dates:  Standard dates 
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-228
Companion FOA: PAR-16-229 R21
R01 NIH
NCI is a participating Institute

NEW
February 05 All Ranks Federal HIV/Aids & Aging

Multidisciplinary Studies of HIV/AIDS and Aging (Clinical Trial Optional)

This FOA encourages applications at the intersection of HIV and aging by addressing two overarching objectives: 1) to improve understanding of biological, clinical, and socio-behavioral aspects of aging through the lens of HIV infection and its treatment; and 2) to improve approaches for testing, prevention, and treatment of HIV infection, and management of HIV-related comorbidities, co-infections, and complications in different populations and cultural settings by applying our current understanding of aging science. 
NCI seeks research studies to help understand how aging in the presence of chronic HIV infection affects the risk, spectrum and biology of cancer (AIDS-defining and non-AIDS-defining cancers).
Due Dates: Feb. 01 (OSR) Ι Feb. 05 (Sponsor)
Additional Due dates: Standard dates
Amount & Project Period: Application budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-18-189
Companion FOA: PAR-18-190 R21 Clinical Trial Optional
R01 NIH
NCI is a participating Institute

NEW
February 05 All ranks Federal Population Health

Population Health Interventions: Integrating Individual and Group Level Evidence (Clinical Trials Not Allowed)

The purpose is to support multilevel, transdisciplinary population health interventions targeting underlying social, economic, and environmental conditions in an effort to improve health outcomes. NCI encourages applications designed to study multi-level interventions aimed at improving cancer prevention and control along any aspect of the cancer control continuum. (See detailed NCI information in Part 2, Section 1 of the FOA).
Due Dates: Feb. 01 (OSR) Ι Feb. 05 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: Application budgets not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-18-356
Companion FOAs: PA-18-406  R21 - Clinical Trials not allowed
PA-18-385  R01 - Clinical Trial Optional
PA-18-407  R21 - Clinical Trial Optional
Standard Due Dates apply for all
R01 NIH
NCI is a participating Institute

NEW
February 05 All Ranks Federal Behavioral & Social factors in Health and Disease

Methodology and Measurement in the Behavioral and Social Sciences (R01 Clinical Trial Optional)

The participating NIH Institutes and Centers (ICs) encourage research that will improve the quality and scientific power of behavioral and social science data relevant to the IC missions. Applicants are strongly encouraged to contact the Scientific/Research Contact (listed in Section VII of the FOA) for the IC that most closely matches the research focus to determine IC interest in the proposed research topic.
Due Dates: Feb. 01 (OSR) Ι Feb. 05 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: Application budgets not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-18-352
Companion FOA: PAR-18-378, R21
K-Awards NCI


Annual Reminder
February 12 All  Ranks Federal Career Development

National Cancer Institute "K" Awards

The purpose of the "K" Awards is to provide opportunities for mentored and non-mentored career development.  NCI supports a variety of mentored and non-mentored career development award programs designed to foster the transition of new investigators to research independence and to support established investigators in achieving specific objectives. NCI is also committed to building the diversity of the biomedical workforce by supporting candidates from backgrounds nationally underrepresented in cancer research and care. 
Due Dates: Unless otherwise specified in FOA, next due date is
Feb. 08 (OSR) | Feb. 12 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: See specific FOA.
Eligibility: Determined from criteria in specific FOA
Contact: Office of Sponsored Research - (x6804)
FOA Links: K99/R00 NIH Pathway to Independence Award (PA-18-397(Independent Clinical Trial Required)) and PA-18-398 (Independent Clinical Trial Not Allowed)
K01 NCI Mentored Research Scientist Development Award to Promote Diversity (Clinical Trial Required) PAR-18-365, and  PAR-18-364  (No independent Clinical Trials)
K08 Mentored Clinical Scientist Research Career Development Award (Independent Clinical Trial Required) PA-18-372, and PA-18-373 (No Independent Clinical Trials)
K12 Paul Calabresi Career Development Award for Clinical Oncology (PAR-18-292) Due Date:  6/15/2018
K22 NCI Transition Career Development Award to Promote Diversity (Clinical Trial Required) PAR-18-367, PAR-18-366 (No Independent Clinical Trials), The NCI Transition Career Development Award PAR-18-467 (Independent Clinical Trial Not Allowed), and PAR-18-466 (Independent Clinical Trial Required)

Also See:    Funding for Extramural Cancer Training by the Cancer Training Branch
R01 NIH
NCI is a participating Institute

NEW
February 13 All Ranks Federal Tobacco

Tobacco Regulatory Science (Clinical Trial Optional)

This FOA seeks applications to support biomedical and behavioral research that will provide scientific data to inform regulation of tobacco products to protect public health.
Due Dates: Feb. 11 (OSR) Ι Feb. 13 (Sponsor)
Additional 2018 Due Date:  Jul.  17
Amount & Project Period: $300,000/yr. (Direct Costs) - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-OD-18-002
Companion RFAs: RFA-OD-18-003  R21 - Tobacco Regulatory Science (Clinical Trial Optional)
RFA-OD-18-001  R03 - Tobacco Regulatory Science Small Grant Program for New Investigators (Clinical Trial Optional)
Note:  For purposes of this RFA, a "New Investigator" is defined as a PD/PI who has not yet competed successfully for a substantial, competing NIH independent research award.  A list of NIH grants that a PD/PI can hold and still be considered eligible is contained in Section III.1. Eligible Applicants
UH2/UH3 NCI

February 14 All Faculty Ranks Federal Assay Validation

Assay Validation of High Quality Markers for Clinical Studies in Cancer (Clinical Trial Not Allowed)

The purpose is to further optimize and validate molecular/cellular/imaging markers and assays for cancer detection, diagnosis, prognosis, monitoring, and prediction of response or resistance to treatment, as well as markers for cancer prevention and control. It also includes the validation of pharmacodynamic markers and markers of toxicity.
The UH2 phase supports analytical validation of assays for these markers that must be achieved within 2 years before assays may undergo clinical validation. The UH3 phase of this FOA supports clinical validation of established assays for up to 3 years using specimens from retrospective or prospective clinical trials or studies.
Due Dates: Jan. 14 (Letter of Intent)
Applications Due: Feb. 12 (OSR) Ι Feb. 14 (Sponsor)
Additional 2018 Due Dates: Jul. 10 & Oct. 8
Amount & Project Period: UH2 - $275,000 (Direct Costs) - 2 years
UH3 - $250,000/yr. (Direct Costs) - 3 years
Eligibility: All Faculty Ranks
Contact: Office of Sponsored Research - (x6804)
FOA Link: PAR-18-317
Companion FOA: PAR-18-310 UH3
R01 NIH
NCI is a participating Institute

NEW
February 16 All Ranks Federal Obesity

Exploratory/Developmental Clinical Research Grants in Obesity (Clinical Trial Optional)

This FOA encourages applications for exploratory/developmental clinical studies to accelerate development of effective interventions for prevention or treatment of overweight or obesity in adults and/or children. Exploratory epidemiological research with a goal of informing translational/clinical research will also be supported within this program. (See NCI interests in FOA Part 2, Section I)
Due Dates: Feb. 14 (OSR) Ι Feb. 16 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: $275,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-18-104
R21 NCI

NEW
February 20 All Ranks Federal Clinical/Translational

NCI Clinical and Translational Exploratory/Developmental Studies  (Clinical Trial Optional)  

This FOA supports development of new exploratory research in cancer diagnosis, treatment, imaging, symptom/toxicity, and prevention clinical trials; correlative studies associated with clinical trials; novel cancer therapeutic, symptom/toxicity, and preventive agent development, radiotherapy development activities, and mechanism-driven combinations; and innovative preclinical studies--including the use of new clinically-relevant models and imaging technologies--which could lead to first-in-human clinical trials.
Due Dates: Feb. 16 (OSR) Ι Feb. 20 (Sponsor)
Additional 2018 Due Dates:  June 19 & Oct. 17
Amount & Project Period: $275,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-18-020
R03 NCI

NEW
February 27 All Ranks Federal Exploratory Research

NCI Small Grants Program for Cancer Research (NCI Omnibus - Clinical Trial Optional)

This FOA supports small research projects on cancer that can be carried out in a short period of time w/limited resources. An R03 grant supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.
Due Dates: Feb. 23 (OSR) Ι Feb. 27 (Sponsor)
Additional 2018 Due Dates:  June 29 & Oct. 26
Amount & Project Period: $50,000/yr. (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-18-021
U54 NCI

NEW
February 27 Established Investigators Federal Health Disparities

Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (Clinical Trial Optional)

The CPACHE Program develops and maintains comprehensive, long-term, and mutually beneficial partnerships between institutions serving underserved health disparity populations and underrepresented students (ISUPSs) and NCI-designated Cancer Centers (CCs). The institutions in each partnership are expected to work collaboratively to: 1) increase the cancer research and cancer research education capacity of the ISUPSs; 2) increase the number of students and investigators from underrepresented populations engaged in cancer research; 3) improve the effectiveness of CCs in developing and sustaining research programs focused on cancer health disparities and increase the number of investigators and students conducting cancer health disparities research; and 4) develop and implement cancer-related activities that benefit the surrounding underserved communities.
Due Dates: Dec. 13 (Letter of Intent, not required, not binding)
Feb. 23 (OSR) Ι Feb. 27 (Sponsor)
Additional Due Dates:  January 9, 2019; January 9, 2020
Amount & Project Period: 2 institutions:  Max. $2M/yr. (Direct Costs)
3 institutions:  Max. $2.5M/yr. (Direct Costs)
Applications exceeding limits will not be accepted.
Duration:  Max. 5 years
Eligibility: Each partnership must include both types of institutions: 1) institutions serving underserved health disparity population and underrepresented students (ISUPSs); and 2) NCI-designated Cancer Centers (CCs). (Partnerships involving more than two institutions require NCI approval before submission of an  application.)
PD(s)/PI(s) are preferred to be mid-to-senior-level scientists w/records of obtaining grants. A less experienced investigator at an ISUPS can be designated as one of multiple PDs/PIs, if there is an appropriate institutional investment in this investigator, and a demonstrable collaboration (active or planned) of the less experienced investigator with a more experienced PD/PI.
The contact PD/PI for the CC must be a CC PD/PI.
Both contact PDs/PIs should be reciprocally listed as PD(s)/PI(s) on the linked application from the partner institution.
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-18-361
R33 NCI

NEW
February 28 All Ranks Federal Biospecimen Science

Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 - Clinical Trial Not Allowed)

This FOA supports further development and validation of emerging technologies improving quality of samples used for cancer research or clinical care. This includes new capabilities to address issues related to pre-analytical degradation of targeted analytes during collection, processing, handling, and/or storage of cancer-relevant biospecimens. For these applications, major feasibility gaps for the technology or methodology have been overcome, as demonstrated with supportive preliminary data, but still require further development and rigorous validation to encourage adoption by the research community.
Due Dates: Jan. 30 (Letter of Intent, not required, not binding)
Feb. 26 (OSR) Ι Feb. 28 (Sponsor)
Additional 2018 Due Dates:  May 29 & Sept. 28
Amount & Project Period: $300,000/yr. (Direct Costs) - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-CA-18-005
Companion RFAs: RFA-CA-18-002, R21 (Clinical Trial Not Allowed)
RFA-CA-18-003, R33 (Clinical Trial Not Allowed)
RFA-CA-18-004, R21 (Clinical Trial Not Allowed)
K18 NIH
NCI is a participating Institute
NEW
March 06 All Ranks Federal Career Enhancement Award

Short-term Mentored Career Enhancement Awards for Mid-Career Investigators to Integrate Basic Behavioral and Social Sciences (No Independent Clinical Trials)

This FOA encourages applications for short-term mentored career development (K18) awards that improve synergies among researchers in basic and applied behavioral-social sciences, human subjects and model animals settings; and biomedical and behavioral-social sciences. It is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants are permitted to propose research experience in a clinical trial led by a mentor or co-mentor.
Due Dates: Mar. 02 (OSR) Ι Mar. 06 (Sponsor)
Additional Due Date: Mar. 06, 2019
Amount & Project Period: May not exceed $100,000 (Total Costs) - 1 year
See FOA for specific costs supported
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-18-349
R21 NCI

NEW
March 12 (LOI) All Ranks Federal Cancer Prevention/Control

Predicting Behavioral Responses to Population-Level Cancer Control Strategies (Clinical Trial Optional)

The goal is to facilitate research to identify individual influences on the effectiveness of population-level strategies that target cancer-related behaviors.
Due Dates: Mar. 12 (Letter of Intent)
Apr. 09 (OSR) Ι Apr. 11 (Sponsor)
Additional Due Dates:  Oct. 10, and Apr. 11, 2019 (w/LOI 30 days prior)
Amount & Project Period: $275,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-18-024
R01 NCI

NEW
March 12 (LOI) All Ranks Federal Health Outcomes

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (Clinical Trial Optional)

This FOA invites applications for intervention research designed to support caregivers of adult cancer patients. Interventions supported by this FOA are intended to provide caregivers with care training, promote coping skills, and ultimately help them manage care. Outcomes of such interventions are expected to (1) optimize patient health care utilization, (2) improve caregiver well-being, and (3) improve patient physical health and psychosocial outcomes.
Due Dates: Mar. 12 (Letter of Intent)
Apr. 09 (OSR) Ι Apr. 11 (Sponsor)
Additional Due Dates: Oct. 10, & Apr. 11, 2019 (w/LOI 30 days prior)
Amount & Project Period: Application budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-18-246
Companion FOA: PAR-18-247  (R21 Clinical Trial Optional)

NEW
March 15 Postdocs Non-federal Career Development

Damon Runyon Cancer Research Foundation
Fellowship Awards

This fellowship award supports all theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies, and prevention.
Due Dates: Mar. 13 (OSR) Ι Mar. 15 (Sponsor)
Note:  This due date is for degrees conferred April 15, 2017 - March 15, 2018, and applicant joined lab on or after April 15, 2017.
Amount & Project Period: $231,000 - 4 years
Eligibility: Applicants must have completed one or more of the following degrees or its equiv.: (MD, PhD, MD/PhD, DDS, and/or DVM).
See Award Overview/Eligibility for additional details.
Contact: Office of Sponsored Research (x6804)
Links: Awards Program Information Ι Award Application Guidelines
Toolbox
Funding Opportunities

Funding Opportunity Calendar
OSR's Grant News
grants.gov
NCI Funding Opportunities
NIH Guide to Grants & Contracts

RaceTracks

 Federal Opportunities
Moffitt-Sponsored (Intramural) Opportunities
Opportunities Focused on Thoracic Oncology		 Grant Preparation

Proposal Submission Form
Grants.gov Instructions
PHS398 Instructions
NIH 2590 Instructions

News

 NIH Research Matters
The Cancer Letter
NIH News & Events
Federal Register
Science 360 News
 Other

PubMed
National Cancer Institute

Clinical Research

Who To Call in Clinical Research
Clinical Research FAQs
Data Safety Monitoring Plan
Liberty IRB
USF IRB
Questions?
MRISignals@moffitt.org